Xtl Biopharmaceuticals (XTLB) Property, Plant & Equipment (Net) (2009 - 2025)

Xtl Biopharmaceuticals (XTLB) Property, Plant & Equipment (Net) (2009 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Oculis Holding AG 66,140.12 Bn 66,139.83 Bn - 642,333.36
2 Nanobiotix 1,912.79 Bn 1,912.73 Bn - 5.32 Mn
3 Akari Therapeutics 1,022.34 Bn 1,022.34 Bn - -
4 BeOne Medicines 472.60 Bn 467.81 Bn 1.35 Bn 1.64 Bn
5 Vertex Pharmaceuticals 122.34 Bn 115.09 Bn 2.59 Bn 1.61 Bn
6 Regeneron Pharmaceuticals 70.14 Bn 61.39 Bn 3.31 Bn 5.27 Bn
7 Belite Bio 62.79 Bn 62.79 Bn - -
8 Argenx Se 56.19 Bn 51.00 Bn 1.41 Bn 1.96 Bn
9 Alnylam Pharmaceuticals 37.50 Bn 34.49 Bn 959.66 Mn 518.26 Mn
10 Xtl Biopharmaceuticals 2.51 Bn 2.51 Bn - 201,000.00

Historic Data

Download Data
DateValue
Dec 31, 2025 201,000.00
Dec 31, 2025 201,000.00
Dec 31, 2024 7.21 Mn
Dec 31, 2024 7.21 Mn
Dec 31, 2023 380,000.00
Dec 31, 2023 380,000.00
Dec 31, 2022 380,000.00
Dec 31, 2022 380,000.00
Jun 30, 2022 381,000.00
Jun 30, 2022 381,000.00
Mar 31, 2022 381,000.00
Mar 31, 2022 381,000.00
Dec 31, 2021 381,000.00
Dec 31, 2021 381,000.00
Sep 30, 2021 382,000.00
Sep 30, 2021 382,000.00
Jun 30, 2021 382,000.00
Jun 30, 2021 382,000.00
Mar 31, 2021 382,000.00
Mar 31, 2021 382,000.00